HR 5429
Medication Affordability and Patent Integrity Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Medication Affordability and Patent Integrity Act aims to increase transparency in the drug approval process by requiring pharmaceutical companies and patent holders to share information between the Food and Drug Administration (FDA) and the United States Patent and Trademark Office (USPTO). Specifically, it mandates the disclosure of data and communications related to patents covering drugs, ensuring that the FDA has a complete understanding of the intellectual property landscape surrounding a drug’s approval. This legislation also establishes a defense against patent infringement lawsuits for those who have complied with disclosure requirements, promoting greater accountability and potentially lowering drug costs.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Ann M. Kuster
Cosponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.